Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.

Saved in:
Bibliographic Details
Title: Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.
Authors: Gompels LL; Faculty of Medicine, Kennedy Institute of Rheumatology, 65 Aspenlea Road, London, W6 8LH, Imperial College London, London, UK., Malik NM, Madden L, Jin P, Feldmann M, Shepard HM, Paleolog EM
Source: Arthritis research & therapy [Arthritis Res Ther] 2011; Vol. 13 (5), pp. R161. Date of Electronic Publication: 2011 Oct 07.
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1478-6362
DOI:10.1186/ar3480